Skip to main content
Equibles

PRN · Profound Medical Corp. · Investor Relations

Use PRN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PRN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
10.1400 CAD +0.5000 (+5.19%) At close · Nov 6 Intraday price with Plus
Rebalance outlook locked

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Date Headline
2026-11-05 Profound Medical Reports Strong Third Quarter 2026 Results; Expands U.S. Distribution and Positions Leadership for Next Phase of Growth
2026-11-03 Profound Medical and Cook Medical’s iMRI Division Partner to Expand U.S. TULSA-PRO ® Sales Channels and Drive Recurring Revenue Growth
2026-10-22 Emmy-Award Winning Television Host Montel Williams to Join Next ‘Let’s Huddle’ Webinar Patient advocacy initiative expands its reach with a nationally recognized voice on health, resilience and informed treatment decisions
2026-10-14 TULSA Abstracts at the 15th Interventional MRI Symposium Strengthen Real-World Evidence, Clinical Differentiation, and Platform Expansion Opportunity
2026-10-09 Profound Medical and Telix Pharmaceuticals Enter Co-Education Agreement to Advance PSMA-Informed Prostate Care
2026-10-07 Profound Medical Reports Strong Preliminary Third Quarter 2026 Revenue Anticipates Q3-2026 revenue of $9.8 million to $10.0 million, exceeding Bloomberg analyst consensus by approximately 45% to 47%
2026-09-04 Profound Medical to Participate in Lake Street’s 10th Annual Best Ideas Growth Conference
2026-09-03 Profound Medical Further Strengthens Executive Leadership Team with Appointment of Richard Fabian as President
2026-08-17 Profound’s Introduction of New Real-time Interventional MRI Software Paving the Way for Full ‘TULSA Days’ Most recent TDC software provides a potential roadmap for customers to easily achieve up to 6 TULSA Procedures™ per system per day
2026-08-17 Profound Medical Announces Management Change
2026-08-13 Profound Medical Launches ‘Let's Huddle’, a Global Community Supporting Men Throughout Their Prostate Care Journey A patient-centered initiative focused on education, connection, and support
2026-08-06 Profound Medical Reports Second Quarter 2026 Financial Results
2026-07-24 Robotic Radical Prostatectomy Comes Up ‘Short’ in CAPTAIN Trial
2026-07-16 Profound Medical to Release Second Quarter 2026 Financial Results on August 6th – Conference Call to Follow
2026-07-15 Profound Medical: Autonomous Robotics and Incisionless Surgery to Have Exceptional Presence at SRS2026
2026-05-14 Profound to Showcase TULSA-PRO®, the TULSA Procedure™ and the Future of iMRI at AUA2026 Company to explore the potential of integrating TULSA-PRO with PSMA PET molecular imaging technologies to enhance ablation planning and monitoring
2026-05-07 Profound Medical Reports Strong First Quarter 2026 Financial Results
2026-04-16 Profound Medical to Release First Quarter 2026 Financial Results on May 7 – Conference Call to Follow
2026-04-14 Profound Medical to Participate in the 2026 Bloom Burton & Co. Healthcare Investor Conference
2026-04-01 Incision-Free, MRI-Guided Prostate Treatment with Profound’s TULSA-PRO® to be Featured in Multiple Presentations at the Upcoming 2026 Society of Interventional Radiology Scientific Meeting
2026-03-27 Profound Medical Congratulates Texas Prostate on Achieving 100th TULSA Procedure™ Milestone
2026-03-13 CAPTAIN Trial Comparing Profound’s MRI-Guided TULSA Procedure™ to Robotic Radical Prostatectomy Successfully Meets Primary Safety Endpoint, Preservation of Erectile Function and Urinary Continence
2026-03-09 Profound Medical to Host Investor Call to Discuss First Clinical Outcomes from the CAPTAIN Trial on March 13; Participate in ROTH Investor Conference on March 22-24
2026-03-05 Profound Medical Reports Fourth Quarter and Full Year 2025 Financial Results
2026-02-12 Profound Medical to Release Fourth Quarter and Full Year 2025 Financial Results on March 5th – Conference Call to Follow

Past events

Date Event Type
2026-11-05 Q3 FY2026 Earnings conference call (announced in 8-K) Earnings call
2026-11-05 Q3 2026 Financial Results Conference Call Earnings call
2026-11-05 Let’s Huddle Event
2026-08-06 Q2 2026 Financial Results Conference Call Earnings call
2026-08-06 Q2 FY2026 Earnings conference call (announced in 8-K) Earnings call
2026-05-07 Q1 FY2026 Earnings conference call (announced in 8-K) Earnings call
2026-03-05 Q4 FY2025 Earnings conference call (announced in 8-K) Earnings call
2025-04-28 Analyst Day 2025 Presentation

Source: https://ir.profoundmedical.com/